{"id":"https://openalex.org/W7204689444","doi":"https://doi.org/10.1016/s2152-2650(26)02668-6","title":"ABCL-1635: Cardiovascular Adverse Event Reporting Patterns With CD19 CAR-T and CD20 \u00d7 CD3 Bispecific Antibodies in Relapsed/Refractory Large B-Cell Lymphoma: A FAERS Disproportionality Analysis","display_name":"ABCL-1635: Cardiovascular Adverse Event Reporting Patterns With CD19 CAR-T and CD20 \u00d7 CD3 Bispecific Antibodies in Relapsed/Refractory Large B-Cell Lymphoma: A FAERS Disproportionality Analysis","alternate_titles":[],"publication_year":2026,"publication_date":"2026-08-01","ids":{"openalex":"https://openalex.org/W7204689444","doi":"https://doi.org/10.1016/s2152-2650(26)02668-6"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(26)02668-6","doi":"https://doi.org/10.1016/s2152-2650(26)02668-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)02668-6","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2669","issn":["2152-2669","2152-2650"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7204689444"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5148681212","display_name":"B\u00fcsranur Yilmaz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]},{"id":"https://openalex.org/I4210130435","display_name":"Klinikum Ludwigshafen","ror":"https://ror.org/037wq4b75","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210130435"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"B\u00fcsranur Yilmaz","raw_affiliation_strings":["Clinic Ludwigshafen, Ludwigshafen, Germany","Heidelberg University, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinic Ludwigshafen, Ludwigshafen, Germany","institution_ids":["https://openalex.org/I4210130435"]},{"raw_affiliation_string":"Heidelberg University, Heidelberg, Germany","institution_ids":["https://openalex.org/I223822909"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148650622","display_name":"Alina Tariq","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405261637","display_name":"Akhtar Saeed Medical and Dental College","ror":"https://ror.org/05kyfde14","country_code":"PK","type":"education","lineage":["https://openalex.org/I4405261637"]}],"countries":["PK"],"is_corresponding":false,"raw_author_name":"Alina Tariq","raw_affiliation_strings":["University of Health Science, Akhtar Saeed Medical and Dental College (ADMC), Lahore, Pakistan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Health Science, Akhtar Saeed Medical and Dental College (ADMC), Lahore, Pakistan","institution_ids":["https://openalex.org/I4405261637"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148728304","display_name":"Tamara Hossein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28109999","display_name":"University of Medicine and Pharmacy of Craiova","ror":"https://ror.org/031d5vw30","country_code":"RO","type":"education","lineage":["https://openalex.org/I28109999"]}],"countries":["RO"],"is_corresponding":false,"raw_author_name":"Tamara Hossein","raw_affiliation_strings":["University of Medicine and Pharmacology of Craiova, Craiova, Romania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Medicine and Pharmacology of Craiova, Craiova, Romania","institution_ids":["https://openalex.org/I28109999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148641481","display_name":"Ioana-Elena Tarabasanu-Mihaila","orcid":"https://orcid.org/0000-0001-8175-2332","observed_orcids":["https://orcid.org/0000-0001-8175-2332"]},"institutions":[{"id":"https://openalex.org/I162051807","display_name":"Carol Davila University of Medicine and Pharmacy","ror":"https://ror.org/04fm87419","country_code":"RO","type":"education","lineage":["https://openalex.org/I162051807"]}],"countries":["RO"],"is_corresponding":false,"raw_author_name":"Ioana-Elena Tarabasanu-Mihaila","raw_affiliation_strings":["Carol Davila University of Medicine and Pharmacy, Bucharest, Romania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","institution_ids":["https://openalex.org/I162051807"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091986784","display_name":"Silvia Halteh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I21215505","display_name":"Al-Quds University","ror":"https://ror.org/04hym7e04","country_code":"PS","type":"education","lineage":["https://openalex.org/I21215505"]}],"countries":["PS"],"is_corresponding":false,"raw_author_name":"Silvia Halteh","raw_affiliation_strings":["Al-Quds University, Jerusalem, Palestine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Al-Quds University, Jerusalem, Palestine","institution_ids":["https://openalex.org/I21215505"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148707606","display_name":"Fatmanur Yilmaz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210156450","display_name":"University Medical Centre Mannheim","ror":"https://ror.org/05sxbyd35","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210156450"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Fatmanur Yilmaz","raw_affiliation_strings":["University Medical Center Mannheim, Mannheim, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Medical Center Mannheim, Mannheim, Germany","institution_ids":["https://openalex.org/I4210156450"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5130733000","display_name":"Bailey Grones","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165139151","display_name":"University of North Texas Health Science Center","ror":"https://ror.org/05msxaq47","country_code":"US","type":"education","lineage":["https://openalex.org/I165139151"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bailey Grones","raw_affiliation_strings":["University of North Texas Health Science Center at Fort Worth, Fort Worth, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Texas Health Science Center at Fort Worth, Fort Worth, TX, USA","institution_ids":["https://openalex.org/I165139151"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":null,"first_page":"S966","last_page":"S966"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.8984000086784363,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.8984000086784363,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.05169999971985817,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.014399999752640724,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adverse-cardiovascular-events","display_name":"cardiovascular adverse events","score":0.9120000004768372},{"id":"https://openalex.org/keywords/cd19-car-t-cell-therapy","display_name":"CD19 CAR T-cell therapy","score":0.8510000109672546},{"id":"https://openalex.org/keywords/cd20-cd3-bispecific-antibody","display_name":"CD20/CD3 bispecific antibody","score":0.972000002861023},{"id":"https://openalex.org/keywords/relapsed-refractory-large-b-cell-lymphoma","display_name":"relapsed/refractory large B-cell lymphoma","score":0.9539999961853027},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/axicabtagene-ciloleucel","display_name":"axicabtagene ciloleucel","score":0.9369999766349792},{"id":"https://openalex.org/keywords/tisagenlecleucel","display_name":"tisagenlecleucel","score":0.9890000224113464},{"id":"https://openalex.org/keywords/lisocabtagene-maraleucel","display_name":"lisocabtagene maraleucel","score":0.9789999723434448},{"id":"https://openalex.org/keywords/brexucabtagene-autoleucel","display_name":"brexucabtagene autoleucel","score":0.9990000128746033},{"id":"https://openalex.org/keywords/epcoritamab","display_name":"epcoritamab","score":0.9950000047683716},{"id":"https://openalex.org/keywords/glofitamab","display_name":"glofitamab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/mosunetuzumab","display_name":"mosunetuzumab","score":1.0},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.7689999938011169},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.36800000071525574}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9610999822616577},{"id":"https://openalex.org/C2777105317","wikidata":"https://www.wikidata.org/wiki/Q4686710","display_name":"Adverse Event Reporting System","level":3,"score":0.7520999908447266},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6317999958992004},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.5992000102996826},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5946999788284302},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5613999962806702},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.548799991607666},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4950000047683716},{"id":"https://openalex.org/C2779662365","wikidata":"https://www.wikidata.org/wiki/Q5416694","display_name":"Event (particle physics)","level":2,"score":0.45500001311302185},{"id":"https://openalex.org/C114684123","wikidata":"https://www.wikidata.org/wiki/Q419458","display_name":"CD3","level":4,"score":0.383899986743927},{"id":"https://openalex.org/C3018127138","wikidata":"https://www.wikidata.org/wiki/Q389735","display_name":"Cardiovascular event","level":3,"score":0.27320000529289246},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.26899999380111694},{"id":"https://openalex.org/C3020495827","wikidata":"https://www.wikidata.org/wiki/Q426141","display_name":"Bispecific antibody","level":4,"score":0.2680000066757202}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(26)02668-6","doi":"https://doi.org/10.1016/s2152-2650(26)02668-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)02668-6","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2669","issn":["2152-2669","2152-2650"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7204714467","https://openalex.org/W7204731730","https://openalex.org/W4414893215","https://openalex.org/W7162445401","https://openalex.org/W7204713304","https://openalex.org/W4399642196","https://openalex.org/W3210942732","https://openalex.org/W4410821212","https://openalex.org/W4417004468","https://openalex.org/W7171033458"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7204689444","counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-08-31T00:00:00"}
